Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Go back to Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
(NASDAQ: MRSN) Delayed: 29.08 --0 (-0%)
Previous Close $29.08    52 Week High
Open $29.08    52 Week Low
Day High $29.08    P/E N/A 
Day Low $29.08    EPS
Volume 6,119,111